JEFFREY S MATHIESEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEFFREY S MATHIESEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEFFREY S MATHIESEN. JEFFREY S MATHIESEN is Vice President and CFO in DELPHAX TECHNOLOGIES INC ($DLPX) and Director in NEUROONE MEDICAL TECHNOLOGIES Corp ($NMTC) and Director in Sun BioPharma, Inc. ($SNBP) and Chief Financial Officer in Gemphire Therapeutics Inc. ($GEMP).
Latest Insider Trading Transactions of JEFFREY S MATHIESEN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DLPX, NRBO, NMTC, SNBP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 03 2020 | SNBP | Panbela Therapeuti ... | MATHIESEN JEFFREY S | Director | Grant | A | 0.00 | 2,875 | 0 | 5,875 | 3 K to 5.9 K (+95.83 %) |
Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 4.98 | 13,700 | 68,226 | 13,700 | |
Jun 17 2020 | NMTC | NEUROONE MEDICAL T ... | MATHIESEN JEFFREY S | Director | Option Exercise | M | 0.04 | 34,020 | 1,191 | 0 | |
Jun 17 2020 | NMTC | NEUROONE MEDICAL T ... | MATHIESEN JEFFREY S | Director | Buy | M | 0.04 | 34,020 | 1,191 | 96,658 | 62.6 K to 96.7 K (+54.31 %) |
Jun 04 2020 | NMTC | NEUROONE MEDICAL T ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 1.48 | 23,725 | 35,113 | 23,725 | |
Jun 04 2020 | NMTC | NEUROONE MEDICAL T ... | MATHIESEN JEFFREY S | Director | Grant | A | 0.00 | 22,371 | 0 | 62,638 | 40.3 K to 62.6 K (+55.56 %) |
Nov 07 2019 | NMTC | NEUROONE MEDICAL T ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.14 | 100,000 | 214,000 | 100,000 | |
Jun 06 2019 | NMTC | NEUROONE MEDICAL T ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.38 | 14,995 | 35,688 | 14,995 | |
Jun 06 2019 | NMTC | NEUROONE MEDICAL T ... | MATHIESEN JEFFREY S | Director | Grant | A | 0.00 | 14,006 | 0 | 14,006 | 0 to 14 K |
May 23 2019 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.95 | 6,800 | 20,060 | 6,800 | |
May 23 2019 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.95 | 27,000 | 79,650 | 27,000 | |
May 15 2019 | NMTC | NEUROONE MEDICAL T ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.38 | 45,605 | 108,540 | 45,605 | |
Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | P | 5.00 | 3,000 | 15,000 | 3,000 | |
Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Buy | P | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Jan 30 2018 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Option Exercise | A | 10.10 | 48,000 | 484,800 | 48,000 | |
Aug 16 2017 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Option Exercise | M | 3.59 | 3,207 | 11,513 | 0 | |
Aug 16 2017 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | M | 3.59 | 3,207 | 11,513 | 14,134 | 10.9 K to 14.1 K (+29.35 %) |
Aug 11 2017 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Option Exercise | M | 3.59 | 3,000 | 10,770 | 0 | |
Aug 11 2017 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | M | 3.59 | 3,000 | 10,770 | 10,927 | 7.9 K to 10.9 K (+37.85 %) |
Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 1.51 | 208,000 | 314,080 | 208,000 | |
Aug 12 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | P | 10.00 | 4,000 | 40,000 | 7,927 | 3.9 K to 7.9 K (+101.86 %) |
Aug 12 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | P | 10.00 | 4,000 | 40,000 | 7,927 | 3.9 K to 7.9 K (+101.86 %) |
Aug 12 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | C | 6.71 | 3,927 | 26,334 | 3,927 | 0 to 3.9 K |
Aug 12 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Buy | C | 6.71 | 3,927 | 26,334 | 3,927 | 0 to 3.9 K |
Aug 08 2016 | GEMP | Gemphire Therapeut ... | MATHIESEN JEFFREY S | Chief Financial Off ... | Option Exercise | A | 10.00 | 210,000 | 2,100,000 | 210,000 | |
Oct 11 2005 | DLPX | DELPHAX TECHNOLOGI ... | MATHIESEN JEFFREY S | Vice President and ... | Option Exercise | A | 2.59 | 20,000 | 51,800 | 20,000 | |
Jan 13 2005 | DLPX | DELPHAX TECHNOLOGI ... | MATHIESEN JEFFREY S | Vice President and ... | Option Exercise | A | 3.73 | 20,000 | 74,600 | 20,000 | |
Jul 13 2004 | DLPX | DELPHAX TECHNOLOGI ... | MATHIESEN JEFFREY S | Vice President and ... | Option Exercise | A | 4.80 | 15,000 | 72,000 | 15,000 | |
Jul 13 2004 | DLPX | DELPHAX TECHNOLOGI ... | MATHIESEN JEFFREY S | Vice President and ... | Option Exercise | A | 4.80 | 15,000 | 72,000 | 15,000 |
Page: 1